These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Is pregnancy associated plasma protein-A (PAPP-A) a marker for adverse perinatal outcomes in preterm isolated oligohydramnios cases? Ozgen G, Dincgez Cakmak B, Dundar B, Tasgoz FN, Bayram F, Karadag B. Taiwan J Obstet Gynecol; 2018 Feb; 57(1):71-75. PubMed ID: 29458908 [Abstract] [Full Text] [Related]
23. Prostaglandin E2 induction of labor and cervical ripening for term isolated oligohydramnios in pregnant women with Bishop score ≤ 5. Kansu-Celik H, Gun-Eryılmaz O, Dogan NU, Haktankaçmaz S, Cinar M, Yilmaz SS, Gülerman C. J Chin Med Assoc; 2017 Mar; 80(3):169-172. PubMed ID: 27745800 [Abstract] [Full Text] [Related]
24. Isolated low-normal amniotic fluid volume in the early third trimester: association with adverse perinatal outcomes. Hashimoto K, Kasdaglis T, Jain S, Atkins K, Harman CR, Baschat AA. J Perinat Med; 2013 Jul; 41(4):349-53. PubMed ID: 23241578 [Abstract] [Full Text] [Related]
27. The impact of amniotic fluid volume assessed intrapartum on perinatal outcome. Baron C, Morgan MA, Garite TJ. Am J Obstet Gynecol; 1995 Jul; 173(1):167-74. PubMed ID: 7631675 [Abstract] [Full Text] [Related]
28. Perinatal outcomes in uncomplicated late preterm pregnancies with borderline oligohydramnios. Sahin E, Madendag Y, Tayyar AT, Sahin ME, Col Madendag I, Acmaz G, Unsal D, Senol V. J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3085-3088. PubMed ID: 28782398 [Abstract] [Full Text] [Related]
29. Misoprostol for cervical ripening and labor induction in pregnancies with oligohydramnios. Dede FS, Haberal A, Dede H, Sivaslioglu A, Arslanpence I. Gynecol Obstet Invest; 2004 Dec; 57(3):139-43. PubMed ID: 14707473 [Abstract] [Full Text] [Related]
30. Earlier gestational age at ultrasound evaluation predicts adverse neonatal outcomes in the preterm appropriate-for-gestational-age fetus with idiopathic oligohydramnios. Vink J, Hickey K, Ghidini A, Deering S, Mora A, Poggi S. Am J Perinatol; 2009 Jan; 26(1):21-5. PubMed ID: 18843586 [Abstract] [Full Text] [Related]
31. [Amniotic fluid analysis as a screening test in term and post-term pregnancy]. Pasquini L, Nasto R, Mie ME, Giuliani B, Periti E. Minerva Ginecol; 2003 Feb; 55(1):69-73. PubMed ID: 12598846 [Abstract] [Full Text] [Related]
32. Peripartum outcomes of high-risk pregnancies complicated by oligo- and polyhydramnios: a prospective longitudinal study. Magann EF, Doherty DA, Lutgendorf MA, Magann MI, Chauhan SP, Morrison JC. J Obstet Gynaecol Res; 2010 Apr; 36(2):268-77. PubMed ID: 20492376 [Abstract] [Full Text] [Related]
34. Oligohydramnios is an independent risk factor for perinatal morbidity among women with pre-eclampsia who delivered preterm. Rabinovich A, Holtzman K, Shoham-Vardi I, Mazor M, Erez O. J Matern Fetal Neonatal Med; 2019 Jun; 32(11):1776-1782. PubMed ID: 29237307 [Abstract] [Full Text] [Related]
36. Isolated oligohydramnios is not an indicator for adverse perinatal outcome. Ahmad H, Munim S. J Pak Med Assoc; 2009 Oct; 59(10):691-4. PubMed ID: 19813684 [Abstract] [Full Text] [Related]
37. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. Valiño N, Giunta G, Gallo DM, Akolekar R, Nicolaides KH. Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608 [Abstract] [Full Text] [Related]
38. Predictive value of amniotic fluid index for oligohydramnios in patients with prolonged pregnancies. O'Reilly-Green CP, Divon MY. J Matern Fetal Med; 1996 Feb; 5(4):218-26. PubMed ID: 8796797 [Abstract] [Full Text] [Related]